Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence.
Luo M, Wong D, Zelley K, Wu J, Schubert J, Denenberg EH, Fanning EA, Chen J, Gallo D, Golenberg N, Patel M, Conlin LK, Maxwell KN, Wertheim GB, Surrey LF, Zhong Y, Brodeur GM, MacFarland SP, Li MM.
Luo M, et al. Among authors: li mm.
J Natl Cancer Inst. 2024 May 3:djae102. doi: 10.1093/jnci/djae102. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 38702830